AngioDynamics to Participate at the 21st Annual Oppenheimer Healthcare Conference
ALBANY, N.Y., Oct 25, 2010 (BUSINESS WIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, today announced that it will present at the 21st Annual Oppenheimer Healthcare Conference at 4:30 p.m. ET on Wednesday, November 3, 2010, at The Waldorf-Astoria Hotel in New York. Joseph Gersuk, Executive Vice President and Chief Financial Officer of AngioDynamics, will review the Company's business strategy and recent corporate developments.
Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's Web site at: http://investors.angiodynamics.com. The archived presentation will be available for 90 days.
AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons and other physicians for the minimally-invasive treatment of cancer and peripheral vascular disease. AngioDynamics' diverse product lines include market-leading radiofrequency and irreversible electroporation ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.angiodynamics.com.
SOURCE: AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 x1608
EVC Group, Inc.
Investor Relations Contacts:
Doug Sherk / Greg Gin
Chris Gale, 646-201-5431
Copyright Business Wire 2010